Combination of Curcuminoid With Acupressure for Inflammation and Pain in the Elderly With Osteoarthritis Genu
- Disease/Condition
- Osteoarthritis, Knee
- Drug/Device/Intervention
- Acupressure and Standardized Curcuminoid from Turmeric Extract
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Gadjah Mada University
- Location
- Sleman, Indonesia
- Phase
- Phase 1/2
- Start date
- Aug 27, 2023
- End date
- Oct 31, 2023
- Enrollment
- 70 participants
Inflammation Marker,Endorphin Hormones
The goal of this clinical trial is to to investigate the efficacy of acupressure and
 standardized curcuminoids from turmeric extract to inflammatory markers, endorphin hormones
 in the blood and quality of life in elderly patient with Osteoarthritis Genu.
 
 The main questions it aims to answer are:
 
 1. Is there any effect combination of acupressure and standardized curcuminoids from
 turmeric extract to inflammatory markers in elderly patients with Osteoarthritis Genu?
 
 2. Is there any effect combination of acupressure and standardized curcuminoids from
 turmeric extract to endorphin hormones in the blood in elderly patients with
 Osteoarthritis Genu?
 
 3. Is there an effect combination of acupressure and standardized curcuminoids from
 turmeric extract to quality of life in elderly patients with Osteoarthritis Genu?
 
 Participants in the intervention group received 2 treatments, namely acupressure at points
 that provide osteoarthritis-specific comfort and standardized curcuminoids from turmeric
 extract capsules. Participant in the control group alo would receive 2 treatments, an active
 placebo (starch capsules and sham acupressure).
 
 Researchers will compare interventional group and sham group to see efficacy the combination
 therapy
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06105840
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06105840 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Gadjah Mada University and is currently Enrolling by invitation. The study focuses on Osteoarthritis, Knee. Target enrollment is 70 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.